For: | Papi A, Orlandi M. Role of nuclear receptors in breast cancer stem cells. World J Stem Cells 2016; 8(3): 62-72 [PMID: 27022437 DOI: 10.4252/wjsc.v8.i3.62] |
---|---|
URL: | https://www.wjgnet.com/1948-0210/full/v8/i3/62.htm |
Number | Citing Articles |
1 |
Marta Ávalos-Moreno, Araceli López-Tejada, Jose L. Blaya-Cánovas, Francisca E. Cara-Lupiañez, Adrián González-González, Jose A. Lorente, Pedro Sánchez-Rovira, Sergio Granados-Principal. Drug Repurposing for Triple-Negative Breast Cancer. Journal of Personalized Medicine 2020; 10(4): 200 doi: 10.3390/jpm10040200
|
2 |
Mingtao Ao, Xianwen Hu, Yuqing Qian, Boqun Li, Jianyu Zhang, Yin Cao, Yuxiang Zhang, Kaiqiang Guo, Yingkun Qiu, Fuquan Jiang, Zhen Wu, Meijuan Fang. Discovery of new chalone adamantyl arotinoids having RXRα-modulating and anticancer activities. Bioorganic Chemistry 2021; 113: 104961 doi: 10.1016/j.bioorg.2021.104961
|
3 |
Varun Khurana, Deep Kwatra, Sujay Shah, Abhirup Mandal, Ashim K. Mitra. Emerging Nanotechnologies for Diagnostics, Drug Delivery and Medical Devices. 2017; : 85 doi: 10.1016/B978-0-323-42978-8.00005-X
|
4 |
Giuseppina Augimeri, Francesca Ida Montalto, Cinzia Giordano, Ines Barone, Marilena Lanzino, Stefania Catalano, Sebastiano Andò, Francesca De Amicis, Daniela Bonofiglio. Nutraceuticals in the Mediterranean Diet: Potential Avenues for Breast Cancer Treatment. Nutrients 2021; 13(8): 2557 doi: 10.3390/nu13082557
|
5 |
Parisa Malakouti, Mobin Mohammadi, Mohammad Amin Boshagh, Abbasali Amini, Mohammad Ali Rezaee, Mohammad Reza Rahmani. Combined effects of pioglitazone and doxorubicin on migration and invasion of MDA-MB-231 breast cancer cells. Journal of the Egyptian National Cancer Institute 2022; 34(1) doi: 10.1186/s43046-022-00110-x
|
6 |
Shaimaa Hussein, Pooja Khanna, Neha Yunus, Michael L. Gatza. Nuclear Receptor-Mediated Metabolic Reprogramming and the Impact on HR+ Breast Cancer. Cancers 2021; 13(19): 4808 doi: 10.3390/cancers13194808
|
7 |
Fulvia Farabegoli, Marzia Govoni, Enzo Spisni, Alessio Papi. EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion. Bioscience Reports 2017; 37(3) doi: 10.1042/BSR20170168
|
8 |
Fulvia Farabegoli, Marzia Govoni, Enzo Spisni, Alessio Papi. Epigallocatechin-3-gallate and 6-OH-11-O-Hydroxyphenanthrene Limit BE(2)-C Neuroblastoma Cell Growth and Neurosphere Formation In Vitro. Nutrients 2018; 10(9): 1141 doi: 10.3390/nu10091141
|